• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Apr 30, 2024
Distillery Therapeutics

Dual membrane- and DNA-targeting antifungal for drug-resistant pathogens

Read More
BioCentury | Apr 15, 2013
Clinical News

Sequus preclinical data

Read More
BioCentury | Apr 15, 2013
Clinical News

The Liposome regulatory update

Read More
BioCentury | Apr 15, 2013
Company News

The Liposome, Wyeth-Ayerst International Inc. deal

Read More
BioCentury | Nov 16, 2009
Company News

Enzon, Sigma-Tau S.p.A. deal

Read More
BioCentury | Nov 16, 2009
Strategy

Leftovers in Enzon's refrigerator

Read More
BioCentury | Nov 10, 2009
Top Story

Enzon to sell specialty pharma business

Read More
BioCentury | Feb 9, 2009
Company News

Enzon drug delivery, infectious, cancer news

Read More
BioCentury | Aug 18, 2008
Company News

Enzon drug delivery, infectious, cancer news

Read More
BioCentury | Aug 12, 2008
Company News

Enzon seeking alternatives for specialty pharma unit

Read More
Items per page:
1 - 10 of 140